Cargando…
Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
SIMPLE SUMMARY: Patients diagnosed with glioblastoma (GBM) brain tumors typically survive less than two years, despite aggressive therapy with surgery, radiation, and chemotherapy. A major factor underlying this lethality is the ability of GBM tumors to adapt to stress, including the stress of treat...
Autores principales: | Caragher, Seamus, Miska, Jason, Shireman, Jack, Park, Cheol H., Muroski, Megan, Lesniak, Maciej S., Ahmed, Atique U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693784/ https://www.ncbi.nlm.nih.gov/pubmed/33114573 http://dx.doi.org/10.3390/cancers12113126 |
Ejemplares similares
-
Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate
por: Muroski, Megan E., et al.
Publicado: (2017) -
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
por: Hasan, Tanwir, et al.
Publicado: (2019) -
Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry
por: Baisiwala, Shivani, et al.
Publicado: (2019) -
Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme
por: Miska, Jason, et al.
Publicado: (2015) -
HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
por: Miska, Jason, et al.
Publicado: (2019)